Enhanced trabeculectomy: the moorfields safer surgery system

PT Khaw, M Chiang, P Shah, F Sii, A Lockwood… - Glaucoma …, 2017 - karger.com
Trabeculectomy with antifibrotic treatment is still the most popular incisional procedure for
glaucoma filtration surgery (GFS) worldwide. The advent of antifibrotic agents reduced …

Novel anti (lymph) angiogenic treatment strategies for corneal and ocular surface diseases

F Bock, K Maruyama, B Regenfuss, D Hos… - Progress in retinal and …, 2013 - Elsevier
The cornea is one of the few tissues which actively maintain an avascular state, ie the
absence of blood and lymphatic vessels (corneal [lymph] angiogenic privilege). Nonetheless …

Novel drug delivery systems fighting glaucoma: Formulation obstacles and solutions

O Rahić, A Tucak, N Omerović, M Sirbubalo, L Hindija… - Pharmaceutics, 2020 - mdpi.com
Glaucoma is considered to be one of the biggest health problems in the world. It is the main
cause of preventable blindness due to its asymptomatic nature in the early stages on the …

Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: a review

M Kim, C Lee, R Payne, BYJT Yue, JH Chang… - Survey of …, 2015 - Elsevier
Angiogenesis may pose a clinical challenge in glaucoma, for example, during the wound
healing phase after glaucoma filtration surgery and in the severe secondary glaucoma …

New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery

A Lockwood, S Brocchini, PT Khaw - Current opinion in pharmacology, 2013 - Elsevier
Despite the advent of many new devices for glaucoma surgery, scarring is the main cause of
suboptimal pressure control and surgical failure in all forms of surgery. The cytotoxic …

[HTML][HTML] VEGF induces TGF-β1 expression and myofibroblast transformation after glaucoma surgery

HYL Park, JH Kim, CK Park - The American journal of pathology, 2013 - Elsevier
Subconjunctival fibrosis at the surgical site determines the outcome of glaucoma surgery.
Myofibroblast transformation has a significant role in fibrosis, and vascular endothelial …

Current perspectives on the use of anti-VEGF drugs as adjuvant therapy in glaucoma

V Andrés-Guerrero, L Perucho-González… - Advances in …, 2017 - Springer
The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the
treatment of neovascular age-related macular degeneration one decade ago marked the …

Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study

JU Akkan, S Cilsim - Journal of glaucoma, 2015 - journals.lww.com
Purpose: To compare the safety and efficacy of primary trabeculectomy with adjunctive
subconjunctival bevacizumab with that of primary trabeculectomy with mitomycin C (MMC) …

Comparative cost-effectiveness of the Baerveldt implant, trabeculectomy with mitomycin, and medical treatment

RI Kaplan, CG De Moraes, GA Cioffi… - JAMA …, 2015 - jamanetwork.com
Importance The Tube vs Trabeculectomy Trial (TVT) found that the 350-mm 2 Baerveldt
implant (tube) and trabeculectomy with mitomycin may be similarly effective in lowering …

Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules

C Yu-Wai-Man, PT Khaw - Expert review of ophthalmology, 2015 - Taylor & Francis
Ocular fibrosis leads to significant visual impairment and blindness in millions of people
worldwide, and is one of the largest areas of unmet need in clinical ophthalmology. The …